Market Overview

Benzinga's Top Initiations

Benzinga's Top Initiations
Related GEVA
Can The Rally In Synageva Biopharma Shares Continue?
Synageva BioPharma Completes Rolling Submission Of Biologics License Application To The FDA For Sebelipase Alfa

Goldman Sachs initiated coverage on shares of Synageva BioPharma (NASDAQ: GEVA) with a “buy” rating. The target price for Synageva BioPharma is set to $72. Synageva BioPharma's shares closed at $52.61 yesterday.

Bank of America initiated coverage on shares of Prothena (NASDAQ: PRTA) with a “neutral” rating. The target price for Prothena is set to $28. Prothena's shares closed at $27.09 yesterday.

Analysts at Mizuho Securities initiated coverage on shares of Abercrombie & Fitch Company (NYSE: ANF) with a “neutral” rating. Abercrombie & Fitch's shares closed at $35.16 yesterday.

Analysts at DA Davidson initiated coverage on shares of Exterran Holdings (NYSE: EXH) with a “neutral” rating. The target price for Exterran Holdings is set to $35. Exterran's shares closed at $32.78 yesterday.

Latest Ratings for GEVA

DateFirmActionFromTo
Oct 2014SunTrust Robinson HumphreyInitiates Coverage onBuy
Jul 2014CitigroupInitiates Coverage onNeutral
Jul 2014JP MorganMaintainsOverweight

View More Analyst Ratings for GEVA
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (ANF + EXH)

Around the Web, We're Loving...

Get Benzinga's Newsletters